ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,169.31
0.28%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,317.47
-0.67%
Brent Oil
82.295
0.21%
Bitcoin
66,133.84
-0.76%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Indaptus Therapeutics Inc (INDP) Share Price

INDP Indaptus Therapeutics Inc

2.47
0.00 (0.00%)
17 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Indaptus Therapeutics Inc NASDAQ:INDP NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 2.47 2.42 2.62 0.00 0.00   00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Medicinal Chems,botanicl Pds  -15.42M -1.8062 -5.33 82.23M
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore INDP News
11/06/202413:00GLOBEIndaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit
07/06/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
07/06/202421:30EDGAR2Form 8-K - Current report
04/06/202413:00GLOBEIndaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference
03/06/202413:00GLOBEIndaptus Therapeutics Announces New Positive Data from Ongoing Phase 1 Trial of Decoy20
30/05/202413:00GLOBEIndaptus Therapeutics to Present at the Jefferies Global Healthcare Conference
29/05/202413:00GLOBEIndaptus Therapeutics to Present New Cohort Data Confirming Original “Pulse-Prime” Hypothesis Via Phase 1 Clinical Trial of Decoy20 at the American Society of Clinical Oncology Annual Meeting
Period
Draw mode
Data Downloads for INDP

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Indaptus Therapeutics Inc Articles